Certain identified information has been omitted from this exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Registrant if publicly disclosed. Such omitted information is indicated by brackets...Term Loan Agreement • March 3rd, 2020 • Sorrento Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 3rd, 2020 Company Industry JurisdictionThis TERM LOAN AGREEMENT, dated as of November 7, 2018, as amended by Amendment No. 1, dated as of May 3, 20192019, and Amendment No. 2, dated as of December 6, 2019, is entered into among SORRENTO THERAPEUTICS, INC., a Delaware corporation (the “Borrower”), the subsidiaries of the Borrower party hereto as Guarantors, the Lenders, and OAKTREE FUND ADMINISTRATION, LLC, in its capacity as administrative agent and collateral agent for the Lenders (together with its permitted successors in such capacity, the “Agent”).
Certain identified information has been omitted from this exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Registrant if publicly disclosed. Such omitted information is indicated by brackets...Term Loan Agreement • May 3rd, 2019 • Sorrento Therapeutics, Inc. • Services-commercial physical & biological research • New York
Contract Type FiledMay 3rd, 2019 Company Industry JurisdictionThis TERM LOAN AGREEMENT, dated as of November 7, 2018, as amended by Amendment No. 1, dated as of May 3, 2019 is entered into among SORRENTO THERAPEUTICS, INC., a Delaware corporation (the “Borrower”), the subsidiaries of the Borrower party hereto as Guarantors, the Lenders, and OAKTREE FUND ADMINISTRATION, LLC, in its capacity as administrative agent and collateral agent for the Lenders (together with its permitted successors in such capacity, the “Agent”).
TERM LOAN AGREEMENT dated as of November 7, 2018 among SORRENTO THERAPEUTICS, INC., as Borrower, CERTAIN SUBSIDIARIES OF SORRENTO THERAPEUTICS, INC., as Guarantors, SC INVESTMENTS NE HOLDINGS, LLC, SC INVESTMENTS E HOLDINGS, LLC, OAKTREE STRATEGIC...Term Loan Agreement • November 9th, 2018 • Sorrento Therapeutics, Inc. • Services-commercial physical & biological research • New York
Contract Type FiledNovember 9th, 2018 Company Industry JurisdictionThis TERM LOAN AGREEMENT, dated as of November 7, 2018, is entered into among SORRENTO THERAPEUTICS, INC., a Delaware corporation (the “Borrower”), the subsidiaries of the Borrower party hereto as Guarantors, the Lenders, and OAKTREE FUND ADMINISTRATION, LLC, in its capacity as administrative agent and collateral agent for the Lenders (together with its permitted successors in such capacity, the “Agent”).